Therapeutic Peptides intermediate
Peptide Gastrointestinal Therapeutics
Therapeutic peptides for GI conditions including IBD, IBS, and motility disorders.
By Encyclopeptide Editorial | 1 min read
gastrointestinal therapeutic IBD IBS motility
Overview
Peptides targeting the GI tract include both luminal and systemic agents for inflammatory, functional, and motility disorders.
Major GI Peptides
| Drug | Indication | Mechanism |
|---|---|---|
| Linaclotide | IBS-C | GC-C agonist |
| Plecanatide | IBS-C, CIC | GC-C agonist |
| Teduglutide | SBS | GLP-2 analog |
Clinical Applications
- Irritable bowel syndrome
- Inflammatory bowel disease
- Short bowel syndrome
- Chronic constipation
Chemical Identity
| Property | Value |
|---|---|
| Name | Peptide Gastrointestinal Therapeutics |
| Category | Therapeutic Peptides |
References
- Encyclopeptide Database. “Peptide Gastrointestinal Therapeutics” monograph. encyclopeptide.com.
Test Your Knowledge
Reinforce what you learned about Peptide Gastrointestinal Therapeutics with interactive quizzes on Wikipept.
Take a Quiz on Wikipept